Elizabeth LaBell

Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor

Patrick C. May, Robert A. Dean, Stephen L. Lowe et al. · Journal of Neuroscience · 2011 · 369 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study

Tim Heise, Helle Linnebjerg, David E. Coutant et al. · Diabetes Obesity and Metabolism · 2020 · 65 citations · Full text

Medicine, Clinical Pharmacy, Pharmacology +6

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial

Helle Linnebjerg, Qianyi Zhang, Elizabeth LaBell et al. · Clinical Pharmacokinetics · 2020 · 57 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Pharmacokinetics and pharmacodynamics of the cathepsin <scp>S</scp> inhibitor, <scp>LY</scp>3000328, in healthy subjects

Christopher D. Payne, Mark A. Deeg, Melanie Chan et al. · British Journal of Clinical Pharmacology · 2014 · 39 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Hydride reagents for stereoselective reductive amination. An improved preparation of 3-endo-tropanamine

John M. McGill, Elizabeth LaBell, MaryAnn Williams · Tetrahedron Letters · 1996 · 32 citations

Natural Sciences, Chemistry, Medicinal Chemistry +6